BNTX logo

BioNTech SE (BNTX) Gross profit

Annual gross profit:

$2.39B-$1.12B(-31.90%)
December 31, 2024

Summary

  • As of today (August 18, 2025), BNTX annual gross profit is $2.39 billion, with the most recent change of -$1.12 billion (-31.90%) on December 31, 2024.
  • During the last 3 years, BNTX annual gross profit has fallen by -$19.93 billion (-89.29%).
  • BNTX annual gross profit is now -89.29% below its all-time high of $22.32 billion, reached on December 31, 2021.

Performance

BNTX Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

quarterly gross profit:

$209.10M+$104.93M(+100.73%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX quarterly gross profit is $209.10 million, with the most recent change of +$104.93 million (+100.73%) on June 30, 2025.
  • Over the past year, BNTX quarterly gross profit has increased by +$134.91 million (+181.85%).
  • BNTX quarterly gross profit is now -96.36% below its all-time high of $5.75 billion, reached on September 30, 2021.

Performance

BNTX quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM gross profit:

$2.49B+$134.91M(+5.72%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX TTM gross profit is $2.49 billion, with the most recent change of +$134.91 million (+5.72%) on June 30, 2025.
  • Over the past year, BNTX TTM gross profit has increased by +$82.22 million (+3.41%).
  • BNTX TTM gross profit is now -88.89% below its all-time high of $22.44 billion, reached on March 31, 2022.

Performance

BNTX TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

BNTX Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-31.9%+181.8%+3.4%
3 y3 years-89.3%-91.9%-87.3%
5 y5 years+3532.1%+425.9%+2031.5%

BNTX Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-89.3%at low-95.0%+3895.0%-87.3%+6.5%
5 y5-year-89.3%+3532.1%-96.4%+3895.0%-88.9%+2031.5%
alltimeall time-89.3%+4970.9%-96.4%+3895.0%-88.9%>+9999.0%

BNTX Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$209.10M(+100.7%)
$2.49B(+5.7%)
Mar 2025
-
$104.17M(-89.7%)
$2.36B(-1.5%)
Dec 2024
$2.39B(-31.9%)
$1.01B(-13.9%)
$2.39B(-14.0%)
Sep 2024
-
$1.17B(+1480.2%)
$2.79B(+15.5%)
Jun 2024
-
$74.19M(-46.8%)
$2.41B(+2.9%)
Mar 2024
-
$139.58M(-90.0%)
$2.34B(-32.5%)
Dec 2023
$3.51B(-80.5%)
$1.40B(+75.3%)
$3.47B(-44.5%)
Sep 2023
-
$798.62M(>+9900.0%)
$6.26B(-23.6%)
Jun 2023
-
$5.23M(-99.6%)
$8.19B(-24.0%)
Mar 2023
-
$1.27B(-69.7%)
$10.77B(-29.1%)
Dec 2022
$18.03B(-19.2%)
$4.19B(+53.5%)
$15.21B(-8.8%)
Sep 2022
-
$2.73B(+5.3%)
$16.68B(-15.3%)
Jun 2022
-
$2.59B(-54.6%)
$19.70B(-12.2%)
Mar 2022
-
$5.70B(+0.7%)
$22.44B(+18.6%)
DateAnnualQuarterlyTTM
Dec 2021
$22.32B(+4524.6%)
$5.66B(-1.5%)
$18.93B(+38.9%)
Sep 2021
-
$5.75B(+7.8%)
$13.63B(+71.4%)
Jun 2021
-
$5.33B(+143.8%)
$7.95B(+198.9%)
Mar 2021
-
$2.19B(+502.7%)
$2.66B(+434.7%)
Dec 2020
$482.56M(+633.3%)
$362.94M(+411.3%)
$497.73M(+209.4%)
Sep 2020
-
$70.98M(+78.5%)
$160.85M(+37.4%)
Jun 2020
-
$39.76M(+65.3%)
$117.03M(+16.9%)
Mar 2020
-
$24.06M(-7.6%)
$100.07M(-2.0%)
Dec 2019
$65.81M(-40.2%)
$26.05M(-4.1%)
$102.08M(-29.0%)
Sep 2019
-
$27.17M(+19.1%)
$143.70M(+4.9%)
Jun 2019
-
$22.80M(-12.5%)
$137.02M(+20.0%)
Mar 2019
-
$26.07M(-61.5%)
$114.22M(+29.6%)
Dec 2018
$110.03M(+133.4%)
$67.66M(+230.3%)
$88.15M(+330.3%)
Sep 2018
-
$20.49M
$20.49M
Dec 2017
$47.14M
-
-

FAQ

  • What is BioNTech SE annual gross profit?
  • What is the all time high annual gross profit for BioNTech SE?
  • What is BioNTech SE annual gross profit year-on-year change?
  • What is BioNTech SE quarterly gross profit?
  • What is the all time high quarterly gross profit for BioNTech SE?
  • What is BioNTech SE quarterly gross profit year-on-year change?
  • What is BioNTech SE TTM gross profit?
  • What is the all time high TTM gross profit for BioNTech SE?
  • What is BioNTech SE TTM gross profit year-on-year change?

What is BioNTech SE annual gross profit?

The current annual gross profit of BNTX is $2.39B

What is the all time high annual gross profit for BioNTech SE?

BioNTech SE all-time high annual gross profit is $22.32B

What is BioNTech SE annual gross profit year-on-year change?

Over the past year, BNTX annual gross profit has changed by -$1.12B (-31.90%)

What is BioNTech SE quarterly gross profit?

The current quarterly gross profit of BNTX is $209.10M

What is the all time high quarterly gross profit for BioNTech SE?

BioNTech SE all-time high quarterly gross profit is $5.75B

What is BioNTech SE quarterly gross profit year-on-year change?

Over the past year, BNTX quarterly gross profit has changed by +$134.91M (+181.85%)

What is BioNTech SE TTM gross profit?

The current TTM gross profit of BNTX is $2.49B

What is the all time high TTM gross profit for BioNTech SE?

BioNTech SE all-time high TTM gross profit is $22.44B

What is BioNTech SE TTM gross profit year-on-year change?

Over the past year, BNTX TTM gross profit has changed by +$82.22M (+3.41%)
On this page